Metabolic changes in patients with prostate cancer during androgen deprivation therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1442-2042|25|1|45-53

ISSN： 0919-8172

Source： INTERNATIONAL JOURNAL OF UROLOGY, Vol.25, Iss.1, 2018-01, pp. : 45-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of the Lipid Profile and Atherogenic Risk during Androgen Deprivation Therapy in Prostate Cancer Patients

By  

Urologia Internationalis, Vol. 90, Iss. 1, 2012-12 ,pp. : 41-44

Karger

Access to resources Recommend Favorite

Androgen Deprivation Therapy in Prostate Cancer - Current Status in M1 Patients

By  

Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. : 646-652

Karger

Access to resources Recommend Favorite

Prospective Study of Estramustine Phosphate for Hormone Refractory Prostate Cancer Patients following Androgen Deprivation Therapy

By  

Urologia Internationalis, Vol. 75, Iss. 1, 2005-07 ,pp. : 43-49

Karger

Access to resources Recommend Favorite

Cognitive function in Chinese prostate cancer patients on androgen‐deprivation therapy: A cross‐sectional study

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 4, 2015-12 ,pp. : 277-281

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Androgen Deprivation Therapy on Volume Reduction and Lower Urinary Tract Symptoms in Patients with Prostate Cancer

By  

LUTS, Vol. 10, Iss. 1, 2018-01 ,pp. : 57-63

John Wiley & Sons Inc

Access to resources Recommend Favorite